Joshua Muia: Our Latest Review on the Proatherogenic Metalloprotease ADAMTS7
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Thrilled to share our newly published review on the proatherogenic metalloprotease ADAMTS7!
Proud of the incredible effort by trainees in my lab, working together with medical students and postdoctoral fellows across Oklahoma State University Center for Health Sciences, National Eye Institute (NIH), Georgetown University Medical Center, and Versiti Blood Research Institute.”
Title: The biology and pathophysiology of the proatherogenic metalloprotease ADAMTS7
Authors: Shiwali Goyal, James Muniu, Mohd Akbar Bhat, Eli Oldham, Derrick Pruitt, Luis Frias Perez, Frida Miranda, Joshua Muia
Read the Full Article on Open Biology
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 7, 2026, 06:19Simone Schoenwaelder: Women Are 25% More Likely to Have Their Stroke Misdiagnosed and Here’s Why
-
Jul 7, 2026, 06:12Dhiraj Bhatia: Extremely Happy to Share Our Review on DNA Nanotechnology in Stroke Repair
-
Jul 7, 2026, 06:04Brian A Beh: An Open Letter to Lisa Murphy Honouring the 30 Years of the Stroke Foundation’s Dedication
-
Jul 7, 2026, 05:55Alan Nurden: A Landmark Review Comparing Hemophilia and Hereditary Angioedema
-
Jul 7, 2026, 05:40Andrew Agwunobi: UConn Health is Proud to Advance Stroke Rehabilitation for Veterans
-
Jul 6, 2026, 22:54Louise St. Germain Bannon: I Wanted to Recognize the Incredible Staff Behind ISTH 2026
-
Jul 6, 2026, 21:46Armghan Ans: UPMC Washington Stroke Program Earns AHA Gold Plus Award for 16th Consecutive Year
-
Jul 6, 2026, 20:31Manik Madaan: Master Transfusion Reactions for USMLE In Less Than 60 Seconds
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention